Natural Products as Inhibitors of COVID-19 Main Protease - A Virtual Screening by Molecular Docking
Background: The novel coronavirus (2019-nCoV) causes a severe respiratory illness unknown to a human before. Its alarmingly quick transmission to many countries across the world has resulted in a global health emergency. Therefore, an imminent need for drugs to combat this disease has been increased...
Saved in:
Main Authors: | Marzieh Omrani (Author), Mohammad Bayati (Author), Parvaneh Mehrbod (Author), Kamal Asmari Bardazard (Author), Samad Nejad-Ebrahimi (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023) -
Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022) -
Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020) -
Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
by: Vishakha Grover, et al.
Published: (2022) -
Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines
by: Marzieh Omrani, et al.
Published: (2021)